サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1590311

DTC (Direct-to-Consumer) 遺伝子検査：世界の市場と各種技術

Direct-to-Consumer Genetic Testing: Global Markets and Technologies

出版日
発行
BCC Research
ページ情報
英文 84 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
DTC (Direct-to-Consumer) 遺伝子検査：世界の市場と各種技術
出版日: 2024年11月08日
発行: BCC Research
ページ情報: 英文 84 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のDTC (Direct-to-Consumer) 遺伝子検査の市場規模は、2024年の23億米ドルから、予測期間中は10.0％のCAGRで推移し、2029年末には37億米ドルの規模に成長すると予測されています。

祖先検査の部門は、2024年の16億米ドルから、CAGR 9.2％で推移し、2029年末には24億米ドルに達すると予測されています。また、健康状態検査の部門は、2024年の5億1,680万米ドルから、CAGR 12.9％で推移し、2029年末には9億4,840万米ドルに達すると予測されています。

当レポートでは、世界のDTC (Direct-to-Consumer) 遺伝子検査の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

  • 市場の展望
  • 調査範囲
  • 市場概要

第2章 市場概要

  • 市場概要と定義
  • 遺伝子検査
  • DTC遺伝子検査の歴史
  • DTC遺伝子検査の種類
  • 規制の枠組み
  • 米国
  • 欧州
  • アジア太平洋

第3章 市場力学

  • 市場力学
  • 市場促進要因
  • ゲノム配列解析のコスト削減
  • 積極的なマーケティング
  • 薬理ゲノム検査
  • 慢性疾患の増加
  • 意識の向上
  • 市場機会
  • 患者と医師の連携の強化
  • 市場抑制要因
  • DTC遺伝子検査の非効率性
  • 限定的な保険適用
  • プライバシーに関する懸念
  • 誤った結果
  • 紹介の増加にかかるコスト
  • 市場の課題
  • サプライチェーンの課題
  • データ管理、品質管理、顧客サービス

第4章 新興技術と開発

  • 概要
  • AI
  • WGSとWES
  • ブロックチェーン技術
  • 医薬品開発におけるゲノムデータ

第5章 DTC遺伝子検査市場

  • セグメンテーションの内訳
  • 市場内訳：製品タイプ別
  • 祖先DTC遺伝子検査市場
  • 健康状態DTC遺伝子検査市場
  • ライフスタイルDTC遺伝子検査市場
  • 地理的内訳
  • 市場内訳：地域別
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第6章 競合情報

  • 業界シナリオ
  • 企業シェア
  • 競合情勢

第7章 DTC遺伝子検査業界における持続可能性：ESGの観点

  • ESG：イントロダクション
  • 環境パフォーマンス
  • 社会的パフォーマンス
  • ガバナンスパフォーマンス
  • BCCからの総論

第8章 特許分析

第9章 付録

  • 調査手法
  • 参考文献
  • 略語
  • 企業プロファイル
  • 23ANDME INC.
  • ANCESTRY
  • COLOR HEALTH INC.
  • DANTE LABS GLOBAL
  • MYDNA LIFE AUSTRALIA PTY LTD.
  • MYHERITAGE LTD.
  • PRIVAPATH DIAGNOSTICS
図表

List of Tables

  • Summary Table : Global DTC Genetic Testing Market, by Product Type, Through 2029
  • Table 1 : DTC Genetic Testing Types
  • Table 2 : Products from Selected DTC Genetic Testing Companies
  • Table 3 : DTC Genetic Testing Synonyms
  • Table 4 : FDA Regulatory Pathways for DTC Genetic Testing
  • Table 5 : DTC Genetic Tests with FDA Marketing Authorization
  • Table 6 : Cases of Diabetes, by Country, 2021
  • Table 7 : Global Incidence of All Cancers, by Region, Estimated and Projected, 2022-2045
  • Table 8 : Global DTC Genetic Testing Market, by Product Type, Through 2029
  • Table 9 : Global DTC Genetic Testing Market, by Technology, Through 2029
  • Table 10 : Global DTC Genetic Testing Market, by Delivery Format, Through 2029
  • Table 11 : Global Ancestry DTC Genetic Testing Market, by Technology, Through 2029
  • Table 12 : Global Health DTC Genetic Testing Market, by Disease Category, Through 2029
  • Table 13 : Global Health DTC Genetic Testing Market, by Technology, Through 2029
  • Table 14 : Global Lifestyle DTC Genetic Testing Market, by Application, Through 2029
  • Table 15 : Global Lifestyle DTC Genetic Testing Market, by Technology, Through 2029
  • Table 16 : Global DTC Genetic Testing Market, by Region, Through 2029
  • Table 17 : North American DTC Genetic Testing Market, by Country, Through 2029
  • Table 18 : European DTC Genetic Testing Market, by Country, Through 2029
  • Table 19 : Asia-Pacific DTC Genetic Testing Market, by Country, Through 2029
  • Table 20 : Latin American DTC Genetic Testing Market, by Country, Through 2029
  • Table 21 : RoW DTC Genetic Testing Market, Through 2029
  • Table 22 : ESG: Environmental Overview
  • Table 23 : ESG: Social Overview
  • Table 24 : ESG: Governance Overview
  • Table 25 : Patents Related to DTC Genetic Testing, January 2020 to September 2024
  • Table 26 : Abbreviations Used in This Report
  • Table 27 : 23andMe Inc.: Company Snapshot
  • Table 28 : 23andMe Inc.: Financial Performance, 2022 and 2023
  • Table 29 : 23andMe Inc.: Product Portfolio
  • Table 30 : 23andMe Inc.: News/Key Developments, 2023
  • Table 31 : Ancestry: Company Snapshot
  • Table 32 : Ancestry: Product Portfolio
  • Table 33 : Color Health Inc.: Company Snapshot
  • Table 34 : Color Health Inc.: Product Portfolio
  • Table 35 : Color Health Inc.: News/Key Developments, 2024
  • Table 36 : Dante Labs Global: Company Snapshot
  • Table 37 : Dante Labs Global: Product Portfolio
  • Table 38 : Dante Labs Global: News/Key Developments, 2023 and 2021
  • Table 39 : myDNA Life Australia Pty Ltd.: Company Snapshot
  • Table 40 : myDNA Life Australia Pty Ltd.: Product Portfolio
  • Table 41 : MyHeritage Ltd.: Company Snapshot
  • Table 42 : MyHeritage Ltd.: Product Portfolio
  • Table 43 : PrivaPath Diagnostics: Company Snapshot
  • Table 44 : PrivaPath Diagnostics: Product Portfolio

List of Figures

  • Summary Figure A : Global DTC Genetic Testing Market, by Product Type, 2021-2029
  • Summary Figure B : Global DTC Genetic Testing Market Shares, by Product Type, 2023
  • Figure 1 : Developments in DTC Genetic Testing Since the 1990s
  • Figure 2 : DTC Genetic Testing: Market Dynamics
  • Figure 3 : Share of All Cancer Cases Globally, by Region, 2022
  • Figure 4 : Emerging Technologies in DTC Genetic Testing
  • Figure 5 : Global DTC Genetic Testing Market Shares, by Product Type, 2023
  • Figure 6 : Global DTC Genetic Testing Market Shares, by Technology, 2023
  • Figure 7 : Global DTC Genetic Testing Market Shares, by Delivery Format, 2023
  • Figure 8 : Global Ancestry DTC Genetic Testing Market Shares, by Technology, 2023
  • Figure 9 : Global Health DTC Genetic Testing Market Shares, by Disease Category, 2023
  • Figure 10 : Global Health DTC Genetic Testing Market Shares, by Technology, 2023
  • Figure 11 : Global Lifestyle DTC Genetic Testing Market Shares, by Application, 2023
  • Figure 12 : Global Lifestyle DTC Genetic Testing Market Shares, by Technology, 2023
  • Figure 13 : Global DTC Genetic Testing Market Shares, by Region, 2023
  • Figure 14 : North American DTC Genetic Testing Market Shares, by Country, 2023
  • Figure 15 : European DTC Genetic Testing Market Shares, by Country, 2023
  • Figure 16 : Asia-Pacific DTC Genetic Testing Market Shares, by Country, 2023
  • Figure 17 : Latin American DTC Genetic Testing Market Shares, by Country, 2023
  • Figure 18 : Global Company Shares of DTC Genetic Testing Market, 2023
  • Figure 19 : ESG Pillars
  • Figure 20 : Advantages of ESG for Companies
  • Figure 21 : 23andMe Inc.: Revenue Shares, by Business Unit, 2023
  • Figure 22 : 23andMe Inc.: Revenue Shares, by Business Unit, 2023
目次
Product Code: MDS008B

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

The ancestry segment of DTC genetic testing market is expected to grow from $1.6 billion in 2024 and is projected to reach $2.4 billion by the end of 2029, at a CAGR of 9.2% during the forecast period of 2024 to 2029.

The health segment of DTC genetic testing market is expected to grow from $516.8 million in 2024 and is projected to reach $948.4 million by the end of 2029, at a CAGR of 12.9% during the forecast period of 2024 to 2029.

Report scope

The report analyzes the market for DTC genetic testing, offering a look at the competitive landscape and the leading companies' revenues, product portfolios and recent developments. The report analyzes trends and market dynamics, including drivers, limitations, challenges and opportunities. It assesses current and potential market size, in order to help industry executives make informed decisions about the production and licensing of goods and services. The study segments the market on the basis of segment/application type, such as ancestry, health and lifestyle. The health market segment is analyzed by technology and by disease category (cancer, cardiovascular, complex common, pharmacogenomics, rare diseases and others). The lifestyle market segment is segmented by technology and application (genetic relatedness, nutrigenomics, personal traits, weight management/fitness and others).

Regional market analysis is provided for all the major segments. The report covers tests that are directly ordered by consumers and consumer-initiated, physician-monitored tests. The DTC genetic testing of animals is outside the scope of the report. Regional market analysis is provided for all the major segments, and this includes some country-level analysis.

This report reviews the main DTC genetic testing technologies, including next-generation sequencing (NGS) and genotyping microarrays.

In this report, the market is divided into the following segments:

Market applications:

  • Ancestry.
  • Health.
  • Lifestyle.

Technologies:

  • Genotyping arrays.
  • Whole genome sequencing (WGS).
  • Whole exome sequencing (WES).
  • Polymerase chain reaction (PCR).
  • Targeted sequencing.

For each segment, current products are identified for the base year of 2023, the current market size is measured and market drivers identified, forecasts are made for 2029, and the current market shares of companies are assessed.

Report Includes

  • 18 data tables and 27 additional tables
  • An overview of the global market and technologies for Direct-to-Consumer Genetic Testing
  • Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the current market size and prospects for revenue growth, accompanied by a market share analysis by product type, and region
  • Forecast of future trends, including regulatory challenges, review of patents, ESG trends and emerging technologies
  • Market share analysis of the key companies in the industry and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other strategies
  • Profiles of the major players, including Ancestry, 23andMe, MyHeritage, myDNA, Dante Labs, and Color Health

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Market Overview and Definitions
  • Genetic Testing
  • History of DTC Genetic Testing
  • Types of DTC Genetic Tests
  • Regulatory Framework
  • United States
  • Europe
  • Asia-Pacific

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Dropping Cost of Genomic Sequencing
  • Aggressive Marketing
  • Pharmacogenomic Testing
  • Increasing Prevalence of Chronic Diseases
  • Increasing Awareness
  • Market Opportunities
  • Enhancing Patient-Physician Collaboration
  • Market Restraints
  • Inefficiencies of DTC Genetic Tests
  • Limited Insurance Coverage
  • Privacy Concerns
  • False Results
  • Costs of Increased Referrals
  • Market Challenges
  • Supply Chain Challenges
  • Data Management, Quality Control and Customer Service

Chapter 4 Emerging Technologies and Developments

  • Overview
  • Artificial Intelligence
  • WGS and WES
  • Blockchain Technology
  • Genomic Data in Drug Development

Chapter 5 DTC Genetic Testing Market

  • Segmentation Breakdown
  • Market Breakdown, by Product Type
  • Ancestry DTC Genetic Testing Market
  • Health DTC Genetic Testing Market
  • Lifestyle DTC Genetic Testing Market
  • Geographic Breakdown
  • Market Breakdown, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Industry Scenario
  • Company Shares
  • Competitive Landscape

Chapter 7 Sustainability in the DTC Genetic Testing Industry: An ESG Perspective

  • Introduction to ESG
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks from BCC

Chapter 8 Patent Analysis

Chapter 9 Appendix

  • Research Methodology
  • References
  • Abbreviations
  • Company Profiles
  • 23ANDME INC.
  • ANCESTRY
  • COLOR HEALTH INC.
  • DANTE LABS GLOBAL
  • MYDNA LIFE AUSTRALIA PTY LTD.
  • MYHERITAGE LTD.
  • PRIVAPATH DIAGNOSTICS